HIV/AIDS Care: The Minimum Package and Scaling Up

  • Joia Mukherjee

Introduction—The Movement to Bring ART to Developing Countries

As recently as 2002, experts argued that prevention should take priority over treatment for HIV/AIDS in Africa based on cost effectiveness considerations. However, cost effectiveness analyses failed to take into account arguably the most important reason for implementing widespread HIV treatment—treating the sick. Twenty years into the epidemic, fewer than 5% of people worldwide who required treatment had access to antiretroviral drugs (ARVs) (WHO, 2002). Additionally, many prevention programs were failing and those that were successful were not being taken to scale.

In 2002, the unchecked spread of HIV and mounting death toll among those who were already infected had widespread and serious effects on the communities most heavily burdened by HIV; ranging from orphaning to famine and from stigma to professional burnout. Where it was available, antiretroviral therapy (ART) resulted in a 80% reduction in mortality (WHO, 2002)....


Public Sector Community Health Worker Global Fund Minimum Package Common Opportunistic Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Banerjee, A., Moyo, S., Salaniponi, F., & Harries, A. (1997). HIV testing and tuberculosis treatment outcome in a rural district in Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 707–708.CrossRefPubMedGoogle Scholar
  2. Bangsberg, D., Hecht, F., Charlebois, E., Zolopa, A.R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load and development of drug resistance in an indigent population. AIDS, 14, 357–366.CrossRefPubMedGoogle Scholar
  3. Bangsberg, D.R., Perry, S., Charlebois, E.D., Clark, R.A., Roberston, M., & Zolopa, A.R. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15, 1–2.CrossRefGoogle Scholar
  4. Chimzizi, R., Gausi, F., Bwanali, A., Mbalume, D., Teck, R., Gomani, P., et al. (2004). Voluntary counselling, HIV testing and adjunctive cotrimoxazole are associated with improved TB treatment outcomes under routine conditions in Thyolo District, Malawi. International Journal of Tuberculosis and Lung Disease, 8, 579–585.PubMedGoogle Scholar
  5. Coovadia, H.M. (2000). Access to voluntary counseling and testing for HIV in developing countries. Annals of the New York Academy of Sciences, 918, 57–63.CrossRefPubMedGoogle Scholar
  6. Day, S., Lakhani, D., & Rodgers, C. (2002). Uptake of HIV testing in patients with a confirmed sexually transmitted infection. Sexually Transmitted Infections, 78, 389–390.CrossRefPubMedGoogle Scholar
  7. de Olalla, P.G., Knobel, H., Carmona, A., Guelar, A., Lopez-Colomes, J.L., et al. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Defiency Syndrome, 30, 105–110.CrossRefGoogle Scholar
  8. Farmer, P., Léandre, F., Mukherjee, J.S., Claude, M., Nevil, P., Smith-Fawzi, M.C., et al. (2001a). Community-based approaches to HIV treatment in resource-poor settings. Lancet, 358, 404–409.CrossRefGoogle Scholar
  9. Farmer, P., Léandre, F., Mukherjee, J.S., Gupta, R., Tarter, L., & Kim, J.Y. (2001b). Community-based approaches to the treatment of advanced HIV disease, introducing DOT-HAART. Bulletin of the World Health Organization, 79, 1145–1151.Google Scholar
  10. Fawzi, W.W., Msamanga, G.I., Spiegelman, D., Wei, R., Kapiga, S., & Villamor, E. (2004). A randomized trial of multivitamin supplements and HIV disease progression and mortality. New England Journal of Medicine, 351, 23–32.Google Scholar
  11. Frater, A.J., Dunn, D.T., Beardall, A.J., Ariyoshi, K., Clarke, J.R., & McClure, M.O. (2002). Comparative response of African HIV-1 infected individuals to highly active antiretroviral therapy. AIDS, 16, 1139–1146.CrossRefPubMedGoogle Scholar
  12. Gandhi, N.R., Moll,. A., Sturm, A.W., Pawinski, R., Govender, T., Lalloo, U., et al. (2006). Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet, 368, 1575–1580.Google Scholar
  13. Gottret, P., & Schieber, G. (2006). Health financing revisited: A practitioner’s guide. Washington, D.C.: The World Bank.CrossRefGoogle Scholar
  14. Harries, A.D., Nyangulu, D.S., Hargreaves, N.J., Kaluwa, O., & Salaniponi, F.M. (2001). Preventing antiretroviral anarchy in Africa. Lancet, 358, 410–414.CrossRefPubMedGoogle Scholar
  15. Harris, S.K., Samples, C.L., Keenan, P.M., Fox, D.J., Melchiono, M.W., & Woods, E.R. (2003). Outreach, mental health, and case management services: Can they help to retain HIV-positive and at-risk youth and young adults in care? Maternal and Child Health Journal, 7, 205–218.CrossRefPubMedGoogle Scholar
  16. The International Treatment Preparedness Coalition (2006). Missing the target: A report on HIV/AIDS treatment access from the frontlines. Retrieved September 2007 from
  17. Kahn, R.H., Moseley, K.E., Thilges, J.N., Johnson, G., & Farley, T.A. (2003). Community-based screening and treatment for STDs: Results from a mobile clinic initiative. Sexually Transmitted Diseases, 30, 654–658.CrossRefPubMedGoogle Scholar
  18. Kosko, D.A., & Becker, K.L. (2000). HIV counseling, testing, and prevention in primary care. Lippincotts Primary Care Practice, 4, 29–39.Google Scholar
  19. Laniece, I., Ciss, M., Desclaux, A., Diop, K., Mbodj, F., Ndiaye, B., et al. (2003). Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS, 17(Suppl 3), S103–S108.Google Scholar
  20. Lucas, G.M., Chaisson, R.E., & Moore, R.D. (1999). Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Annals of Internal Medicine, 131, 81–87.PubMedGoogle Scholar
  21. Ndekha, M.J., Manary, M.J., Ashorn, P., & Briend, A. (2005). Home-based therapy with ready-to-use therapeutic food is of benefit to malnourished, HIV-infected Malawian children. Acta Paediatrica, 94, 222–225.CrossRefPubMedGoogle Scholar
  22. Nuwaha, F., Kabatesi, D., Muganwa, M., & Whalen, C.C. (2002). Factors influencing acceptability of voluntary counselling and testing for HIV in Bushenyi district of Uganda. East Africa Medical Journal, 79, 626–632.Google Scholar
  23. Orrell, C., Bangsberg, D.R., Badri, M., & Wood, R. (2003). Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS, 17, 1369–1375.CrossRefPubMedGoogle Scholar
  24. Phillips, K.A., & Fernyak, S. (2000). The cost-effectiveness of expanded HIV counselling and testing in primary care settings: A first look. AIDS, 14, 2159–2169.CrossRefPubMedGoogle Scholar
  25. Roeloffs, C., Sherbourne, C., Unutzer, J., Fink, A., Tang, L., & Wells, K.B. (2003). Stigma and depression among primary care patients. General Hospital Psychiatry, 25, 311–315.Google Scholar
  26. Rowe, K.A., Makhubele, B., Hargreaves, J.R., Porter, J.D., Hausler, H.P., & Pronyk, P.M. (2005). Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: Implications for antiretroviral delivery in resource-poor settings? International Journal of Tuberculosis and Lung Disease, 9, 263–269.PubMedGoogle Scholar
  27. Russell, S. (2004). The economic burden of illness for households in development countries: A review of the studies focusing on malaria, tuberculosis and HIV/AIDS. American Journal of Tropical Medicine and Hygiene, 71, 147–155.PubMedGoogle Scholar
  28. Rutengwe, R.M. (2004). Identifying strategic interventions for improving household food and nutrition security in an urban informal settlement, South Africa. Asia Pacific Journal of Clinical Nutrition, 13 (Suppl), S169.Google Scholar
  29. Segurado, A.C., Miranda, S.D., Latorre, M.D., & Brazilian Enhancing Care Initiative Team (2003). Evaluation of the care of women living with HIV/ AIDS in São Paulo, Brazil. AIDS Patient Care STDs, 17, 85–93.Google Scholar
  30. Sivaram, S., & Celentano, D.D. (2003). Training outreach workers for AIDS prevention in rural India: Is it sustainable? Health Policy and Planning, 18, 411–420.Google Scholar
  31. Smith Fawzi, M.C., Lambert, W., Singler, J.M., et al. (2005). Factors associated with forced sex among women in rural Haiti: Implications for the prevention of HIV and other STDs. Social Science & Medicine, 60, 679–689.Google Scholar
  32. Steiner, J.F., & Prochazka, A.V. (1997). The assessment of refill compliance using pharmacy records: Methods, validity and applications. Clinical Epidemiolology, 50, 105–116.CrossRefGoogle Scholar
  33. Tay, E.G., & Emmanuel, S.C. (2003). Improving the uptake of human immunodeficiency virus (HIV) antenatal screening in a primary healthcare setting. Annals of the Academy of Medicine Singapore, 32, 92–95.Google Scholar
  34. van Dyk, A.C., & van Dyk, P.J. (2003). “To know or not to know": Service-related barriers to voluntary HIV counseling and testing (VCT) in South Africa. Curationis, 26, 4–10.PubMedGoogle Scholar
  35. Villamor, E., Saathoff, E., Manji, K., Msamanga, G., Hunter, D.J., & Fawzi, W.W. (2005). Vitamin supplements, socioeconomic status, and morbidity events as predictors of wasting in HIV-infected women from Tanzania. American Journal of Clinical Nutrition, 82, 857–865.Google Scholar
  36. Walton, D., Farmer, P., Lambert, W., Leandre, F., Koenig, S., & Mukherjee, J.S. (2004). Integrated HIV prevention and care strengthens primary health care: Lessons from rural Haiti. Journal of Public Health Policy, 25, 137–158.CrossRefPubMedGoogle Scholar
  37. Weinstock, H., Dale, M., Gwinn, M., Satten, G.A., Kothe, D., Mei, J., et al. (2002 ). HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States. Journal of Acquired Immune Deficiency Syndrome, 29, 478–483.Google Scholar
  38. Weiser, S., Wolfe, W., Bangsberg, D., Thior, I., Gilbert, P., Makhema, J., et al. (2003). Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. Journal of Acquired Immune Deficiency Syndrome, 34, 281–288.Google Scholar
  39. Westheimer, E.F., Urassa, W., Msamanga, G., Baylin, A., Wei, R., Aboud, S., et al. (2004). Acceptance of HIV testing among pregnant women in Dar-es-Salaam, Tanzania. Journal of Acquired Immune Deficiency Syndrome, 37, 1197–1205.Google Scholar
  40. WHO, Department of HIV/AIDS (2002). Estimates of ARV Treatment Needs 2003–2005.Retrieved December 2, 2007 from
  41. WHO (2004). Rapid HIV tests: Guidelines for use in HIV testing and counseling services in resource-constrained settings. Geneva: World Health Organization.Google Scholar
  42. WHO (2008). Global Tuberculosis Control- surveillance, planning, financing. Geneva: World Health Organization.Google Scholar
  43. Wilkinson, D., Wilkinson, N., Lombard, C., Martin, D., Smith, A., Floyd, K., et al. (1997). On-site HIV testing in resource-poor settings: Is one rapid test enough? AIDS, 11, 377–381.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Joia Mukherjee
    • 1
  1. 1.Brigham and Women’s HospitalBostonUSA

Personalised recommendations